Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Shares Outstanding (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Shares Outstanding for 13 consecutive years, with $67.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 3.24% year-over-year to $67.8 million, compared with a TTM value of $67.8 million through Sep 2025, up 3.24%, and an annual FY2024 reading of $66.3 million, up 1.09% over the prior year.
  • Shares Outstanding was $67.8 million for Q3 2025 at Tandem Diabetes Care, roughly flat from $67.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $67.8 million in Q3 2025 and bottomed at $62.6 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $64.9 million, with a median of $64.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 4.16% in 2021, then decreased 0.07% in 2024.
  • Year by year, Shares Outstanding stood at $63.8 million in 2021, then grew by 1.07% to $64.5 million in 2022, then rose by 1.61% to $65.6 million in 2023, then grew by 1.09% to $66.3 million in 2024, then grew by 2.28% to $67.8 million in 2025.
  • Business Quant data shows Shares Outstanding for TNDM at $67.8 million in Q3 2025, $67.5 million in Q2 2025, and $66.6 million in Q1 2025.